Form 4 for CL Colgate-Palmolive
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001225208-26-002612 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 2026-02-23 | CL | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | A - Grant | $0.00 | +25.7K | 34.7K | +287% | $0 | |
| 2026-02-25 | 2026-02-23 | CL | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | F - Tax | $97.10 | -13.1K | 21.6K | -38% | -$1.27M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | A | A | 25,742 | $0.00 | 34,710 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-23 | F | D | 13,081 | $97.10 | 21,629 | D | — | — |